Registro:

Referencias:

• Ohtsubo, K., Marth, J.D., Glycosylation in cellular mechanisms of health and disease (2006) Cell, 126, pp. 855-867
• Van Kooyk, Y., Rabinovich, G.A., Protein-glycan interactions in the control of innate and adaptive immune responses (2008) Nat. Immunol., 9, pp. 593-601
• Laine, R.A., The information-storing potential of the sugar code (1997) Glycosciences Status and Perspectives, pp. 1-14. , S.G. Hans, J. Gabius, Chapman & Hall GmbH Weinheim
• Boscher, C., Dennis, J.W., Nabi, I.R., Glycosylation: Galectins and cellular signaling (2011) Curr. Opin. Cell Biol., 23, pp. 383-392
• Stewart, B.W., Wild, C.P., (2014) World Cancer Report 2014, , I.A.f.R.o.C.-. WHO (ed.), IARC publication to be distributed by WHO Press
• Hakomori, S., Glycosylation defining cancer malignancy: New wine in an old bottle (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 10231-10233
• Meezan, E., Wu, H.C., Black, P.H., Robbins, P.W., Comparative studies on carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. Separation of glycoproteins and glycopeptides by sephadex chromatography (1969) Biochemistry, 8, pp. 2518-2524
• Lau, K.S., Dennis, J.W., N-glycans in cancer progression (2008) Glycobiology, 10, pp. 750-760
• Miwa, H.E., Song, Y., Alvarez, R., Cummings, R.D., Stanley, P., The bisecting GlcNAc in cell growth control and tumor progression (2012) Glycoconj. J., 29, pp. 609-618
• Kimura, T., Finn, O.J., MUC1 immunotherapy is here to stay (2013) Expert Opin. Biol. Ther., 13, pp. 35-49
• Bull, C., Stoel, M.A., Den Brok, M.H., Adema, G.J., Sialic acids sweeten a tumor's life (2014) Cancer Res., 74, pp. 3199-3204
• Fuster, M.M., Esko, J.D., The sweet and sour of cancer: Glycans as novel therapeutic targets (2005) Nat. Rev. Cancer, 5, pp. 526-542
• Dube, D.H., Bertozzi, C.R., Glycans in cancer and inflammation - Potential for therapeutics and diagnostics (2005) Nat. Rev. Drug Discov., 4, pp. 477-488
• Mariño, K., Bones, J., Kattla, J., Rudd, P., A systematic approach to protein glycosylation analysis: A path through the maze (2010) Nat. Chem. Biol., 6, pp. 713-723
• Pinho, S.S., Reis, C.A., Glycosylation in cancer: Mechanisms and clinical implications (2015) Nat. Rev. Cancer., 15 (9)
• García-Vallejo, J.J., Van Dijk, W., Van Het Hof, B., Van Die, I., Engelse, M.A., Van Hinsbergh, V.W., Gringhuis, S.I., Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes (2006) J. Cell Physiol., 206, pp. 203-210
• Rabinovich, G.A., Van Kooyk, Y., Cobb, B.A., Glycobiology of immune responses (2012) Ann. N.Y. Acad. Sci., 1253, pp. 1-15
• Toscano, M.A., Ilarregui, J.M., Bianco, G.A., Campagna, L., Croci, D.O., Salatino, M., Rabinovich, G.A., Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity? (2007) Cytokine Growth Factor Rev., 18, pp. 57-71
• Gabius, H., Special issue: Animal lectins (2002) Biochim. Biophys. Acta., 1572, pp. 165-434
• Barondes, S.H., Lectins in cellular slime molds (1986) The Lectins: Properties, Functions, and Applications in Biology and Medicine, pp. 467-491. , I. Liener, N. Sharon, I. Goldstein, Academic Press London
• Kilpatrick, D.C., Animal lectins: A historical introduction and overview (2002) Biochim. Biophys. Acta., 1572, pp. 187-197
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Hirabayashi, J., Arata, Y., Kasai, K., Frontal affinity chromatography as a tool for elucidation of sugar recognition properties of lectins (2003) Methods Enzymol., 362, pp. 353-368
• Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions (2006) Glycobiology, 16, pp. 137R-157R
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
• Cedeno-Laurent, F., Opperman, M., Barthel, S.R., Kuchroo, V.K., Dimitroff, C.J., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression (2012) J. Immunol., 188, pp. 3127-3313
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 13134-13139
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Giaccia, A.J., Le, Q.T., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res., 71, pp. 4423-4431
• Kuo, P.L., Hung, J.Y., Huang, S.K., Chou, S.H., Cheng, D.E., Jong, Y.J., Hung, C.H., Huang, M.S., Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway (2011) J. Immunol., 186, pp. 1521-1530
• Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., Chen, M., Jiang, K., High expression of galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2012) Int. J. Cancer, 130, pp. 2337-2348
• Tang, D., Gao, J., Wang, S., Yuan, Z., Ye, N., Chong, Y., Xu, C., Jiang, K., Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer (2015) Tumor Biol., 36, pp. 5617-5626
• Martínez-Bosch, N., Fernández-Barrena, M.G., Moreno, M., Ortiz-Zapater, E., Munné-Collado, J., Iglesias, M., André, S., Navarro, P., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation (2014) Cancer Res., 74, pp. 3512-3524
• Soldati, R., Berger, E., Zenclussen, A.C., Jorch, G., Lode, H.N., Salatino, M., Rabinovich, G.A., Fest, S., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments (2012) Int. J. Cancer., 131, pp. 1131-1141
• Verschuere, T., Toelen, J., Maes, W., Poirier, F., Boon, L., Tousseyn, T., Mathivet, T., De Vleeschouwer, S., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity (2014) Int. J. Cancer, 134, pp. 873-884
• Baker, G.J., Chockley, P., Yadav, V.N., Doherty, R., Ritt, M., Sivaramakrishnan, S., Castro, M.G., Lowenstein, P.R., Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity (2014) Cancer Res., 74, pp. 5079-5090
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Mendez-Huergo, S.P., Stupirski, J.C., Salatino, M., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease (2013) Cancer Res., 73, pp. 1107-1117
• Rutkowski, M.R., Stephen, T.L., Svoronos, N., Allegrezza, M.J., Tesone, A.J., Perales-Puchalt, A., Brencicova, E., Conejo-García, J.R., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell, 27, pp. 27-40
• Dardalhon, V., Anderson, A.C., Karman, J., Apetoh, L., Chandwaskar, R., Lee, D.H., Cornejo, M., Kuchroo, V.K., Tim-3/galectin-9 pathway: Regulation of Th1 immunity through CD11b+Ly-6G+ myeloid cells (2010) J. Immunol., 185, pp. 1383-1392
• Zhou, Q., Munger, M.E., Veenstra, R.G., Weigel, B.J., Hirashima, M., Munn, D.H., Murphy, W.J., Blazar, B.R., Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia (2011) Blood, 117, pp. 4501-4510
• Demotte, N., Stroobant, V., Courtoy, P.J., Van Der Smissen, P., Colau, D., Luescher, I.F., Hivroz, C., Van Der Bruggen, P., Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes (2008) Immunity, 28, pp. 414-424
• Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Ohyama, C., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) EMBO J., 30, pp. 3173-3185
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Rabinovich, G.A., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma (2012) J. Exp. Med., 209, pp. 1985-2000
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Mendez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Toscano, M.A., Rabinovich, G.A., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy (2012) Nat. Rev. Cancer, 12, pp. 252-264
• Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy (2007) Nat. Nanotechnol., 2, pp. 751-760
• Soler-Illiaand, G.J., Azzaroni, O., Multifunctional hybrids by combining ordered mesoporous materials and macromolecular building blocks (2011) Chem. Soc. Rev., 40, pp. 1107-1150
• Platform, E.T., (2013) Nanomedicine 2020 - Contribution of Nanomedicine to Horizon 2020, , http://www.etp-nanomedicine.eu/public/press-documents/publications/etpn-publications, White Paper to the Horizon 2020 Framework Programme for Research and Innovation, European Comission
• Thakor, A.S., Gambhir, S.S., Nanooncology: The future of cancer diagnosis and therapy (2013) CA Cancer J. Clin., 63, pp. 395-418
• Lin, W.E., Special issue: Nanoparticles in medicine (2015) Chem. Rev., 115, pp. 10407-10409
• Ryu, J.H., Lee, S., Son, S., Kim, S.H., Leary, J.F., Choi, K., Kwon, I.C., Theranostic nanoparticles for future personalized medicine (2014) J. Control. Release., 190, pp. 477-484
• Fang, J., Nakamura, H., Maeda, H., The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect (2011) Adv. Drug Deliv. Rev., 63, pp. 136-151
• Wagner, V., Dullaart, A., Bock, A.K., Zweck, A., The emerging nanomedicine landscape (2006) Nat. Biotechnol., 24, pp. 1211-1217
• Svenson, S., Clinical translation of nanomedicines (2012) Curr. Opin. Solid State Mater. Sci., 16, pp. 287-294
• Farokhzad, O.C., Langer, R., Impact of nanotechnology on drug delivery (2009) ACS Nano, 3, pp. 16-20
• Zhang, L., Gu, F.X., Chan, J.M., Wang, A.Z., Langer, R.S., Farokhzad, O.C., Nanoparticles in medicine: Therapeutic applications and developments (2008) Clin. Pharmacol. Ther., 83, pp. 761-769
• Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F., Farokhzad, O.C., Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation (2012) Chem. Soc. Rev., 41, pp. 2971-3010
• Shi, J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: From discovery to applications (2010) Nano Lett., 10, pp. 3223-3230
• Kobayashi, T., Cancer hyperthermia using magnetic nanoparticles (2011) Biotechnol. J., 6, pp. 1342-1347
• Kennedy, L.C., Bickford, L.R., Lewinski, N.A., Coughlin, A.J., Hu, Y., Day, E.S., West, J.L., Derezek, L.A., A new era for cancer treatment: Gold-nanoparticle-mediated thermal therapies (2011) Small, 7, pp. 169-183
• Liu, J., Detrembleur, C., Mornet, S., Jérôme, C., Duguet, E., Design of hybrid nanovehicles for remotely triggered drug release: An overview (2015) J. Mater. Chem. B, 3, pp. 6117-6147
• Alberti, S., Soler-Illia, G.J.A.A., Azzaroni, O., Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: Controlled delivery and molecular transport in response to chemical, physical and biological stimuli (2015) Chem. Commun., 51, pp. 6050-6075
• Melancon, M.P., Zhou, M., Li, C., Cancer theranostics with near-infrared light-activatable multimodal nanoparticles (2011) Acc. Chem. Res., 44, pp. 947-956
• La Thangue, N.B., Kerr, D.J., Predictive biomarkers: A paradigm shift towards personalized cancer medicine (2011) Nat. Rev. Clin. Oncol., 8, pp. 587-596
• Diamandis, M., White, N.M.A., Yousef, G.M., Personalized medicine: Marking a new epoch in cancer patient management (2010) Mol. Cancer Res., 8, pp. 1175-1187
• Jokerstand, J.V., Gambhir, S.S., Molecular imaging with theranostic nanoparticles (2011) Acc. Chem. Res., 44, pp. 1050-1060
• Kim, C.S., Tonga, G.Y., Solfiell, D., Rotello, V.M., Inorganic nanosystems for therapeutic delivery: Status and prospects (2013) Adv. Drug Deliv. Rev., 65, pp. 93-99
• Cheng, Z., Al Zaki, A., Hui, J.Z., Muzykantov, V.R., Tsourkas, A., Multifunctional nanoparticles: Cost versus benefit of adding targeting and imaging capabilities (2012) Science, 338, pp. 903-910
• Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F., Farokhzad, O.C., Targeted polymeric therapeutic nanoparticles: Design: Development and clinical translation (2012) Chem. Soc. Rev., 41, pp. 2971-3010
• Min, Y., Caster, J.M., Eblan, M.J., Wang, A.Z., Clinical translation of nanomedicine (2015) Chem. Rev., 115, pp. 11147-11190
• Åkerman, M.E., Chan, W.C.W., Laakkonen, P., Bhatia, S.N., Ruoslahti, E., Nanocrystal targeting in vivo (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 12617-12621
• Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., Lammers, T., Noninvasive imaging of nanomedicines and nanotheranostics: Principles, progress, and prospects (2015) Chem. Rev., 115, pp. 10907-11093
• Bergna, H.E., Roberts, W.O., (2005) Colloidal Silica: Fundamentals and Applications, , CRC Press
• Hudson, S., Cooney, J., Magner, E., Proteins in mesoporous silicates (2008) Angew. Chem. Int. Ed., 47, pp. 8582-8594
• Rimola, A., Costa, D., Sodupe, M., Lambert, J.F., Ugliengo, P., Silica surface features and their role in the adsorption of biomolecules: Computational modeling and experiments (2013) Chem. Rev., 113, pp. 4216-4313
• Scodeller, P., Catalano, P.N., Salguero, N., Duran, H., Wolosiuk, A., Soler-Illia, G.J.A.A., Hyaluronan degrading silica nanoparticles for skin cancer therapy (2013) Nanoscale, 5, pp. 9690-9698
• Ashley, C.E., Carnes, E.C., Phillips, G.K., Padilla, D., Durfee, P.N., Brown, P.A., Hanna, T.N., Brinker, C.J., The targeted delivery of multicomponent cargos to cancer cell by nanoporous particle-supported lipid bilayers (2011) Nat. Mater., 10
• Li, Z., Barnes, J.C., Bosoy, A., Stoddart, J.F., Zink, J.I., Mesoporous silica nanoparticles in biomedical applications (2012) Chem. Soc. Rev., 41, pp. 2590-2605
• Knežević, N.Z., Ruiz-Hernández, E., Hennink, W.E., Vallet-Regí, M., Magnetic mesoporous silica-based core/shell nanoparticles for biomedical applications (2013) RSC Adv., 3, pp. 9584-9593
• Jankiewicz, B.J., Jamiola, D., Choma, J., Jaroniec, M., Silica-metal core-shell nanostructures (2012) Adv. Colloid Interface Sci., 170, pp. 28-47
• Lane, L.A., Qian, X., Smith, A.M., Nie, S., Physical chemistry of nanomedicine: Understanding the complex behaviors of nanoparticles in vivo (2015) Annu. Rev. Phys. Chem., 66, pp. 521-547
• Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery (2013) Nat. Mater., 12, pp. 991-1003
• Adak, A.K., Li, B.Y., Lin, C.C., Advances in multifunctional glycosylated nanomaterials: Preparation and applications in glycoscience (2015) Carbohydr. Res., 405, pp. 2-12
• Conde, J., Dias, J.T., Grazú, V., Moros, M., Baptista, P.V., De La Fuente, J.M., Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine (2014) Front. Chem., 2, p. 48
• Seeberger, P.H., Automated carbohydrate synthesis as platform to address fundamental aspects of glycobiology-current status and future challenges (2008) Carbohydr. Res., 343, pp. 1889-1896
• De La Fuente, J.M., Barrientos, A.G., Rojas, T.C., Rojo, J., Cañada, J., Fernández, A., Penadés, S., Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions (2001) Angew. Chem. Int. Ed., 40, pp. 2258-2261
• Hölemann, A.F., Seeberger, P.H., Carbohydrate diversity: Synthesis of glycoconjugates and complex carbohydrates (2004) Curr. Opin. Biotechnol., 15, pp. 615-622
• Garca, I., Marradi, M., Penadés, S., Glyconanoparticles: Multifunctional nanomaterials for biomedical applications (2010) Nanomedicine, 5, pp. 777-792
• Wang, X., Ramström, O., Yan, M., Dynamic light scattering as an efficient tool to study glyconanoparticle- lectin interactions (2011) Analyst, 136, pp. 4174-4178
• Zhou, J., Hao, N., De Zoyza, T., Yan, M., Ramström, O., Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery (2015) Chem. Commun., 51, pp. 9833-9836
• Daniel, M.C., Astruc, D., Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology (2004) Chem. Rev., 104, pp. 293-346
• Brust, M., Fink, J., Bethell, D., Schiffrin, D.J., Kiely, C., Synthesis and reactions of functionalised gold nanoparticles (1995) J. Chem. Soc. Chem. Commun., 165, pp. 1655-1656
• Marradi, M., Chiodo, F., García, I., Penadés, S., Glyconanoparticles as multifunctional and multimodal carbohydrate systems (2013) Chem. Soc. Rev., 42, pp. 4728-4745
• Rojo, J., Díaz, V., De La Fuente, J.M., Segura, I., Barrientos, A.G., Riese, H.H., Bernad, A., Penadés, S., Gold glyconanoparticles as new tools in antiadhesive therapy (2004) ChemBioChem, 5, pp. 291-297
• Otsuka, H., Akiyama, Y., Nagasaki, Y., Kataoka, K., Quantitative and reversible lectin-induced association of gold nanoparticles modified with α-Lactosyl-ω-mercapto-poly(ethylene glycol) (2001) J. Am. Chem. Soc., 123, pp. 8226-8230
• Lin, C.-C., Yeh, Y.-C., Yang, C.-Y., Chen, G.-F., Chen, Y.-C., Wu, Y.-C., Chen, C.-C., Quantitative analysis of multivalent interactions of carbohydrate-encapsulated gold nanoparticles with concanavalin A (2003) Chem. Commun., pp. 2920-2921
• Adak, A.K., Lin, H.J., Lin, C.C., Multivalent glycosylated nanoparticles for studying carbohydrate-protein interactions (2014) Org. Biomol. Chem., 12, pp. 5563-5573
• Marradi, M., Chiodo, F., Garcia, I., Glyconanotechnology and disease: Gold nanoparticles coated with glycosides as multivalent systems for potential applications in diagnostics and therapy (2015) RSC Drug Dis. Ser., 2015 (JANUARY), pp. 89-131
• Zhou, L., Yuan, J., Wei, Y., Core-shell structural iron oxide hybrid nanoparticles: From controlled synthesis to biomedical applications (2011) J. Mater. Chem., 21, pp. 2823-2840
• Van Kasteren, S.I., Campbell, S.J., Serres, S., Anthony, D.C., Sibson, N.R., Davis, B.G., Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 18-23
• Ei-Boubbou, K., Zhu, D.C., Vasileiou, C., Borhan, B., Prospen, D., Wei, L.I., Huang, X., Magnetic glyco-nanoparticles: A tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging (2010) J. Am. Chem. Soc., 132, pp. 4490-4499
• Marradi, M., Alcántara, D., De La Fuente, J.M., García-Martín, M.L., Cerdán, S., Penadés, S., Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: Tuning relaxivities with sugars (2009) Chem. Commun., pp. 3922-3924
• Kottari, N., Chabre, Y.M., Sharma, R., Roy, R., Applications of glyconanoparticles as sweet glycobiological therapeutics and diagnostics (2013) Advances in Polymer Science, 254, pp. 297-342. , P.K. Duttaand, J. Dutta, Springer Berlin Heidelberg
• Solís, D., Bovin, N.V., Davis, A.P., Jiménez-Barbero, J., Romero, A., Roy, R., Smetana, K., Jr., Gabius, H.J., A guide into glycosciences: How chemistry, biochemistry and biology cooperate to crack the sugar code (2015) Biochim. Biophys. Acta., 1850, pp. 186-235
• Roy, R., Shiao, T.C., Rittenhouse-Olson, K., Glycodendrimers: Versatile tools for nanotechnology (2013) Braz. J. Pharm. Sci., 49, pp. 85-108
• Percec, V., Wilson, D.A., Leowanawat, P., Wilson, C.J., Hughes, A.D., Kaucher, M.S., Hammer, D.A., Ropponen, J., Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures (2010) Science, 328, pp. 1009-1014
• Zhang, S., Moussodia, R.O., Sun, H.J., Leowanawat, P., Muncan, A., Nusbaum, C.D., Chelling, K.M., Percec, V., Mimicking biological membranes with programmable glycan ligands self-assembled from amphiphilic Janus glycodendrimers (2014) Angew. Chem. Int. Ed., 53, pp. 10899-10903
• Christiansen, M.N., Chik, J., Lee, L., Anugraham, M., Abrahams, J.L., Packer, N.H., Cell surface protein glycosylation in cancer (2014) Proteomics, 14, pp. 525-546
• Barchi, J.J., Glyco-nanoparticles as platforms for antitumor therapeutic strategies (2011) ACS Symp. Ser., 1091, pp. 161-179
• Sungsuwan, S., Yin, Z., Huang, X., Lipopeptide-coated iron oxide nanoparticles as potential glycoconjugate-based synthetic anticancer vaccines (2015) ACS Appl. Mater. Interfaces, 7, pp. 17535-17544
• Parry, A.L., Clemson, N.A., Ellis, J., Bernhard, S.S.R., Davis, B.G., Cameron, N.R., 'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines (2013) J. Am. Chem. Soc., 135, pp. 9362-9365
• Shiao, T.C., Roy, R., Glycodendrimers as functional antigens and antitumor vaccines (2012) New J. Chem., 36, pp. 324-339
• Zhang, S., Moussodia, R.O., Murzeau, C., Sun, H.J., Klein, M.L., Vértesy, S., André, S., Percec, V., Dissecting molecular aspects of cell interactions using glycodendrimersomes with programmable glycan presentation and engineered human lectins (2015) Angew. Chem. Int. Ed.
• Rosenberger, I., Strauss, A., Dobiasch, S., Weis, C., Szanyi, S., Gil-Iceta, L., Alonso, E., Jiménez-González, M., Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer (2015) J. Control. Release, 214, pp. 76-84
• Danhier, F., Messaoudi, K., Lemaire, L., Benoit, J.P., Lagarce, F., Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation (2015) Int. J. Pharm., 15, pp. 154-161
• Aykaç, A., Martos-Maldonado, M.C., Casas-Solvas, J.M., Quesada-Soriano, I., García-Maroto, F., García-Fuentes, L., Vargas-Berenguel, A., β-Cyclodextrin-bearing gold glyconanoparticles for the development of site specific drug delivery systems (2014) Langmuir, 14, pp. 234-242
• Reynolds, J.L., Law, W.C., Mahajan, S.D., Aalinkeel, R., Nair, B., Sykes, D.E., Yong, K.T., Schwartz, S.A., Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages (2012) J. Neuroimmune Pharmacol., 7, pp. 673-685

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------